Yahoo Finance

Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb

Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "Merkel Cell Carcinoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ...

Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762

Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026King of Prussia, ...

Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762

Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026King of Prussia, Pennsylvania--(Newsfile Corp. - December 23, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) ...
TipRanks on MSN

Phio advances PH-762 with FDA-backed toxicology study

Phio Pharmaceuticals ( ($PHIO) ) has provided an announcement. On December 23, 2025, Phio Pharmaceuticals announced that the U.S. Food and Drug ...
PharmiWeb

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based ...

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

Christmas without my mum, Skye Gyngell

My mum, the chef and restaurateur Skye Gyngell, was a workaholic in the most passionate sense. Her greatest loves were Holly and me, but work came a close second. She came to life in the kitchen or ...
Cleveland Daily Banner

Child's question inspires drive to create Nativity scene

Often times, it takes the perspective of a youngster to realize something is amiss. For example, look at the beautiful ...
Managed Healthcare Executive

What IRA drug prices will mean for PBMs, health plans and patients

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS will use the annual formulary review process to ensure that plans cover all ...
Le Lézard

TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone

TuHURA Biosciences, Inc. ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that Kintara's REM ...

Norgine Pharmaceuticals Limited: Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals.Vir Biotechnology's chronic hepatitis ...
Le Lézard

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing ...

Vir Biotechnology, Inc. today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive license for ...